National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

Introduction More than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) today will survive. However, half of the survivors are expected to experience therapy-related chronic or late occurring adverse effects, reducing quality of life. Insight into underlying risk trajecto...

Full description

Saved in:
Bibliographic Details
Main Authors: Kjeld Schmiegelow, Trine-Lise Lambine, Liv Andrés-Jensen, Mette Tiedemann Skipper, Kristian Mielke Christensen, Pia Hedegaard Johnsen, Katrine Aagaard Myhr, Martin Kaj Fridh, Kathrine Grell, A. M. L. Pedersen, Sune Leisgaard Mørck Rubak, Martin Ballegaard, Arne Hørlyck, Rikke Beck Jensen, Kim Gjerum Nielsen, Ruta Tuckuviene, Peder Skov Wehner, Birgitte Klug Albertsen, Thomas Leth Frandsen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/2/e045543.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/11/2/e045543.full

Similar Items